Clinical trial
Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease…
NCT00146978 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00146978 |
|---|---|
| Title | Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD) |
| Official title | A Phase 1/2 Study to Evaluate Intra-Arterial Catheter Directed Therapy for Severe Gastro-Intestinal and/or Hepatic Graft vs. Host Disease (GVHD) |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Graft vs Host Disease |
| Intervention type | Procedure |
| Interventions | intra-arterial treatment |
| Enrollment | 50 |
| Start date | Dec 1, 2000 |
| Completion | Aug 1, 2005 |
| First posted | Sep 7, 2005 |
| Last update posted | Nov 7, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: